The only FDA-approved antithrombotic for the prophylaxis of VTE for hip fracture surgery patients.
ARIXTRA is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients undergoing hip replacement, knee replacement, or hip fracture surgery.
www.arixtra.com/   reviews